H22 Cells
€800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The H22 cell line is a murine hepatocellular carcinoma cell line derived from liver tumor cells. These cells are commonly used in cancer research to study liver cancer mechanisms, therapeutic interventions, and drug efficacy. H22 cells exhibit typical characteristics of hepatocellular carcinoma, including rapid proliferation, resistance to apoptosis, and the ability to form tumors when injected into suitable animal models. This makes them a valuable tool for in vivo studies aiming to understand tumor growth, metastasis, and the tumor microenvironment in liver cancer. One of the significant advantages of the H22 cell line is its use in immunotherapy research. Since the cells are derived from a murine model, they are particularly useful for studying the interactions between cancer cells and the immune system in a controlled environment. Researchers utilize H22 cells to evaluate the efficacy of various immunotherapeutic agents, including checkpoint inhibitors and cancer vaccines. Additionally, H22 cells are employed in the investigation of liver-specific metabolic pathways and the role of genetic mutations in hepatocellular carcinoma progression. Overall, the H22 cell line serves as a robust model for hepatocellular carcinoma, providing insights into cancer biology and aiding in the development of novel therapeutic strategies. Its relevance to both in vitro and in vivo studies underscores its importance in the field of cancer research. |
|---|---|
| Organism | Mouse |
| Tissue | Liver |
| Disease | Hepatocellular carcinoma |
| Synonyms | Hepatoma-22, Hepatoma 22 |
Characteristics
| Breed/Subspecies | C3HA |
|---|---|
| Morphology | Lymphoblast |
| Growth properties | Suspension |
Regulatory Data
| Citation | H22 (Cytion catalog number 305163) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 10090 |
| CellosaurusAccession | CVCL_H613 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Subculturing | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305163-170325 | Certificate of Analysis | 23. May. 2025 | 305163 |
| 305163-070624 | Certificate of Analysis | 23. May. 2025 | 305163 |
| 305163-041023 | Certificate of Analysis | 23. May. 2025 | 305163 |
| 305163-241022 | Certificate of Analysis | 23. May. 2025 | 305163 |
Material Transfer Agreement
If you intend to use Cytion cell lines solely for internal research at a single research site, please complete and sign our Material Transfer Agreement (MTA) and submit it along with your order.
For any commercial applications - including but not limited to fee-for-service work, quality control testing, product release, diagnostic use, or regulatory studies - please complete the Intended Use Form so we can prepare a suitable agreement tailored to your project.
Please note: The MTA applies only to certain cell lines. If this notice and the MTA document appear on a product page, the agreement is applicable. For cell lines not covered by the MTA, no reference to the agreement will be shown. The MTA is not valid for customers in the Americas, China, or Taiwan. Please contact our U.S. entity to receive the appropriate agreement.